China SXT Pharmaceuticals, Inc.

Filing Type: 6-K
Filing Date: 20220121

Documents

REPORT OF FOREIGN PRIVATE ISSUER
6-K
UNDERWRITING AGREEMENT BY AND BETWEEN CHINA SXT PHARMACEUTICALS, INC. AND AEGIS CAPITAL CORP, DATED JANUARY 18, 2022
EX-1.1
FORM OF WARRANT AGENT AGREEMENT (INCLUDING THE FORM OF PRE-FUNDED WARRANT)
EX-4.1
OPINION OF CAMPBELLS LEGAL (BVI) LIMITED
EX-5.1
OPINION OF HUNTER TAUBMAN FISCHER & LI LLC
EX-5.2
PRESS RELEASE TITLED: "CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF ORDINARY SHARES AND PRE-FUNDED WARRANTS TO PURCHASE ORDINARY SHARES," DATED JANUARY 14, 2022
EX-99.1
PRESS RELEASE TITLED: "CHINA SXT PHARMACEUTICALS, INC. PRICES $3.5 MILLION UNDERWRITTEN PUBLIC OFFERING OF ORDINARY SHARES AND PRE-FUNDED WARRANTS TO PURCHASE ORDINARY SHARES," DATED JANUARY 18, 2022
EX-99.2
PRESS RELEASE TITLED: "CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES SUCCESSFUL CLOSING OF $4.1 MILLION FOLLOW-ON UNDERWRITTEN OFFERING OF ORDINARY SHARES AND PRE-FUNDED WARRANTS WITH SIMULTANEOUS EXERCISE OF THE OVER-ALLOTMENT," DATED JANUARY 20, 2022
EX-99.3